IMAC (BACK) Competitors $1.13 +0.02 (+1.80%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BACK vs. NVOS, MGRX, CNTG, NIVF, ACON, GBNHF, UPHL, BTTX, AVHIW, and AVHIUShould you be buying IMAC stock or one of its competitors? The main competitors of IMAC include Novo Integrated Sciences (NVOS), Mangoceuticals (MGRX), Centogene (CNTG), NewGenIvf Group (NIVF), Aclarion (ACON), Greenbrook TMS (GBNHF), UpHealth (UPHL), Better Therapeutics (BTTX), Achari Ventures Holdings Corp. I (AVHIW), and Achari Ventures Holdings Corp. I (AVHIU). IMAC vs. Novo Integrated Sciences Mangoceuticals Centogene NewGenIvf Group Aclarion Greenbrook TMS UpHealth Better Therapeutics Achari Ventures Holdings Corp. I Achari Ventures Holdings Corp. I IMAC (NASDAQ:BACK) and Novo Integrated Sciences (NASDAQ:NVOS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, community ranking, institutional ownership, earnings, valuation and profitability. Do analysts recommend BACK or NVOS? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IMAC 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ANovo Integrated Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has better valuation & earnings, BACK or NVOS? IMAC has higher revenue and earnings than Novo Integrated Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIMAC$16.19M0.08-$9.42MN/AN/ANovo Integrated Sciences$12.57M0.27-$13.22MN/AN/A Does the media refer more to BACK or NVOS? In the previous week, IMAC had 29 more articles in the media than Novo Integrated Sciences. MarketBeat recorded 29 mentions for IMAC and 0 mentions for Novo Integrated Sciences. IMAC's average media sentiment score of 0.17 beat Novo Integrated Sciences' score of 0.00 indicating that IMAC is being referred to more favorably in the media. Company Overall Sentiment IMAC Neutral Novo Integrated Sciences Neutral Is BACK or NVOS more profitable? IMAC has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -179.95%. IMAC's return on equity of 0.00% beat Novo Integrated Sciences' return on equity.Company Net Margins Return on Equity Return on Assets IMACN/A N/A -205.29% Novo Integrated Sciences -179.95%-122.84%-68.11% Does the MarketBeat Community favor BACK or NVOS? IMAC and Novo Integrated Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformIMACOutperform VotesNo VotesUnderperform Votes1100.00% Novo Integrated SciencesN/AN/A Which has more risk & volatility, BACK or NVOS? IMAC has a beta of 0.25, meaning that its stock price is 75% less volatile than the S&P 500. Comparatively, Novo Integrated Sciences has a beta of -1.61, meaning that its stock price is 261% less volatile than the S&P 500. Do institutionals & insiders hold more shares of BACK or NVOS? 5.8% of IMAC shares are owned by institutional investors. Comparatively, 5.7% of Novo Integrated Sciences shares are owned by institutional investors. 4.6% of IMAC shares are owned by insiders. Comparatively, 10.4% of Novo Integrated Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryIMAC beats Novo Integrated Sciences on 8 of the 11 factors compared between the two stocks. Ad Porter & CompanyTrue paradigm shiftI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Get IMAC News Delivered to You Automatically Sign up to receive the latest news and ratings for BACK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BACK vs. The Competition Export to ExcelMetricIMACSpecialty outpatient clinics IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.30M$1.61B$5.40B$8.53BDividend YieldN/AN/A5.15%4.14%P/E RatioN/A4.59112.5515.07Price / Sales0.0810.991,478.8293.55Price / CashN/A10.6539.8334.04Price / Book-1.711.394.645.01Net Income-$9.42M$36.27M$119.13M$225.46M7 Day Performance-11.02%-8.11%0.78%0.37%1 Month Performance2.73%-9.66%5.65%3.57%1 Year Performance-28.48%-50.82%36.90%29.42% IMAC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BACKIMACN/A$1.13+1.8%N/A-30.7%$1.30M$16.19M0.00180NVOSNovo Integrated SciencesN/A$0.22flatN/A-92.4%$4.14M$13.52M0.00127Positive NewsMGRXMangoceuticals1.2046 of 5 stars$2.42-1.6%N/A-98.5%$4.82M$730,000.00-0.383News CoverageCNTGCentogeneN/AN/AN/AN/A$4.16M$48.54M0.00810Gap UpNIVFNewGenIvf Group0.7485 of 5 stars$0.90-15.1%N/AN/A$3.36M$5.14M0.00N/ANews CoverageACONAclarion2.4157 of 5 stars$0.18-14.0%$1.50+712.1%-96.3%$1.52M$53,947.000.007Short Interest ↑News CoverageGap UpGBNHFGreenbrook TMSN/A$0.01flatN/AN/A$600,000.00$73.79M-0.01430Gap UpUPHLUpHealthN/A$0.00flatN/AN/A$38,000.00$130M0.001,750BTTXBetter TherapeuticsN/AN/AN/AN/A$5,000.00N/A0.0040News CoverageAVHIWAchari Ventures Holdings Corp. IN/A$0.01flatN/AN/A$0.00N/A0.003AVHIUAchari Ventures Holdings Corp. IN/A$10.00flatN/AN/A$0.00N/A0.003 Related Companies and Tools Related Companies Novo Integrated Sciences Competitors Mangoceuticals Competitors Centogene Competitors NewGenIvf Group Competitors Aclarion Competitors Greenbrook TMS Competitors UpHealth Competitors Better Therapeutics Competitors Achari Ventures Holdings Corp. I Competitors Achari Ventures Holdings Corp. I Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BACK) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMAC Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMAC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
